Abstract
The aim of antimicrobial management or stewardship programmes is to ensure proper use of antimicrobial agents in order to provide the best treatment outcomes, to lessen the risk of adverse effects (including antimicrobial resistance), and to promote cost-effectiveness. Increasingly, long-term sustainability is found to be the major focus of antimicrobial stewardship. Implementing structural measures in healthcare institutions is therefore a major, but not the sole, focus of attention in promoting prudent use of antibiotics. The problem of antimicrobial resistance requires common strategies at all levels--for the prescribers and at ward, departmental, hospital, national and international levels.
References
Feb 5, 2000·The Journal of Hospital Infection·I M Gould
Jan 17, 2003·LDI Issue Brief·Joshua P Metlay
Dec 26, 2003·Pharmacotherapy·Karl Madaras-Kelly
Oct 15, 2005·Clinical Microbiology Reviews·Conan MacDougall, Ron E Polk
Apr 21, 2006·The Journal of Antimicrobial Chemotherapy·Richard Wise
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Tamar F Barlam, Margarita DiVall
Jul 21, 2006·The Journal of Antimicrobial Chemotherapy·Fiona M MacKenzieUNKNOWN ARPAC Steering Group
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
Nov 17, 2007·International Journal of Antimicrobial Agents·Steliana HuhulescuMichael Dworzak
Citations
Feb 21, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·A KossowF Kipp
Aug 17, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C-L YeoL-Y Hsu
Apr 5, 2012·Foodborne Pathogens and Disease·Ginger M Shipp, James S Dickson
Jun 12, 2008·Wiener klinische Wochenschrift·Vlastimil JindrákUNKNOWN Working Group on Monitoring Antimicrobial Resistance
Jun 12, 2008·Wiener klinische Wochenschrift·Franz AllerbergerUNKNOWN ABS International
Jun 12, 2008·Wiener klinische Wochenschrift·Sigrid Metz-Gercek, Helmut Mittermayer
Jun 12, 2008·Wiener klinische Wochenschrift·Raffaella KoncanGiuseppe Cornaglia
Jun 12, 2008·Wiener klinische Wochenschrift·Marc J StruelensUNKNOWN Belgian Antibiotic Policy Coordination Committee (BAPCOC)-Hospital Care Working Group
Jun 12, 2008·Wiener klinische Wochenschrift·Milan CizmanAlenka Ovnic
Jun 12, 2008·Wiener klinische Wochenschrift·Johan Struwe
Jun 12, 2008·Wiener klinische Wochenschrift·Winfried V KernKatja de With
Jun 12, 2008·Wiener klinische Wochenschrift·Heinz BurgmannUNKNOWN ABS Group
Jun 12, 2008·Wiener klinische Wochenschrift·Vladimir Krcmery, Erich Kalavsky
Jun 12, 2008·Wiener klinische Wochenschrift·Gabor TernakEva Rakoczi
Jun 12, 2008·Wiener klinische Wochenschrift·Anna Olczak-PienkowskaWaleria Hryniewicz
Mar 13, 2009·Wiener klinische Wochenschrift·Burkhard SpringerHelmut Mittermayer
Feb 6, 2013·Virulence·Cheston B CunhaEleftherios Mylonakis
Jun 4, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C VerchevalT Van Hees
Feb 15, 2020·PloS One·Terence LeeUNKNOWN Australian Group on Antimicrobial Resistance
Nov 6, 2008·Animal Health Research Reviews·John F Prescott
Jun 29, 2013·Current Opinion in Infectious Diseases·Deirdre J O'Brien, Ian M Gould
Jun 1, 2015·Ci Ji Yi Xue Za Zhi = Tzu-chi Medical Journal·Rashed Noor, Md Sakil Munna
Jun 8, 2018·The Journal of Antimicrobial Chemotherapy·Annelie A MonnierUNKNOWN DRIVE-AB WP1 group